These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1650225)

  • 1. Some chemical and biological properties of the low molecular weight heparan sulfate alpha-idosane.
    Gervasi GB; Bartoli C; Farina C; Catalani R; Carpita G; Pistelli N
    Arzneimittelforschung; 1991 Apr; 41(4):410-3. PubMed ID: 1650225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between structure, fat-clearing and anticoagulant properties of heparins and heparan sulphates.
    Casu B; Johnson EA; Mantovani M; Mulloy B; Oreste P; Pescador R; Prino G; Torri G; Zoppetti G
    Arzneimittelforschung; 1983; 33(1):135-42. PubMed ID: 6219676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "In vitro" fibrinolytic activity of a new low molecular weight heparan sulfate.
    Gervasi GB; Farina C; Catalani R; Bartoli C; Baldacci M
    Thromb Res; 1990 Sep; 59(6):931-9. PubMed ID: 2148227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HIV type 1 properties of chemically modified heparins with diminished anticoagulant activity.
    Lopalco L; Ciccomascolo F; Lanza P; Zoppetti G; Caramazza I; Leoni F; Beretta A; Siccardi AG
    AIDS Res Hum Retroviruses; 1994 Jul; 10(7):787-93. PubMed ID: 7986584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-hemorrhagic hybrid heparin/heparan sulfate with anticoagulant potential.
    Brito AS; Cavalcante RS; Palhares LC; Hughes AJ; Andrade GP; Yates EA; Nader HB; Lima MA; Chavante SF
    Carbohydr Polym; 2014 Jan; 99():372-8. PubMed ID: 24274520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A heparin-like compound isolated from a marine crab rich in glucuronic acid 2-O-sulfate presents low anticoagulant activity.
    Andrade GP; Lima MA; de Souza Junior AA; Fareed J; Hoppensteadt DA; Santos EA; Chavante SF; Oliveira FW; Rocha HA; Nader HB
    Carbohydr Polym; 2013 Apr; 94(1):647-54. PubMed ID: 23544586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ion exchange chromatographic separation and isolation of oligosaccharides of intact low-molecular-weight heparin for the determination of their anticoagulant and anti-inflammatory properties.
    Shastri MD; Johns C; Hutchinson JP; Khandagale M; Patel RP
    Anal Bioanal Chem; 2013 Jul; 405(18):6043-52. PubMed ID: 23712644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic effects of heparin and related agents.
    Hladovec J; Kornalík F
    Cor Vasa; 1991; 33(1):68-74. PubMed ID: 1655354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new low molecular weight heparan sulphate antagonizes kappa-carrageenan-induced thrombosis in rats.
    Gervasi GB; Bartoli C; Carpita G
    Pharmacol Res; 1991 Jul; 24(1):59-63. PubMed ID: 1658763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fibrinolytic and anticoagulant complexes of low-molecular heparin with tuftsin].
    Kudriashov BA; Ashmarin IP; Liapina LA; Pastorova VE
    Biull Eksp Biol Med; 1992 Dec; 114(12):609-11. PubMed ID: 1337992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low anticoagulant activity of high sulphated heparan sulphates.
    Kovensky J; Sassetti B; Fernández Cirelli A; Kordich L
    Thromb Haemost; 1990 Jun; 63(3):488-92. PubMed ID: 2144921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological studies on the low molecular weight heparin derivative CY 216.
    Kaiser B; Kühnemuth G; Markwardt F
    Pharmazie; 1990 Jul; 45(7):522-4. PubMed ID: 2173004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometric methods for the analysis of heparin and heparan sulfate.
    Lech M; Capila I; Kaundinya GV
    Methods Mol Biol; 2015; 1229():119-28. PubMed ID: 25325949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low molecular weight fucoidan and heparin enhance the basic fibroblast growth factor-induced tube formation of endothelial cells through heparan sulfate-dependent alpha6 overexpression.
    Chabut D; Fischer AM; Colliec-Jouault S; Laurendeau I; Matou S; Le Bonniec B; Helley D
    Mol Pharmacol; 2003 Sep; 64(3):696-702. PubMed ID: 12920206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA
    Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Action of nonsteroidal anti-inflammatory agents on fibrinolysis and platelet aggregation].
    Lakin KM; Schipilowa SJ; Nowikowa NW; Rukasenkow JE; Pomojnezkij WD; Grenadjorow SJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):230-5. PubMed ID: 2427406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparan sulfate fractions: pharmacological properties and effect on smooth muscle cell proliferation in vitro.
    Cingi MR; Tiozzo R; Croce MA
    Int J Tissue React; 1993; 15(2):77-83. PubMed ID: 8144316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput turbidimetric screening for heparin-neutralizing agents and low-molecular-weight heparin mimetics.
    Sekiya A; Oishi S; Fujii N; Koide T
    Chem Pharm Bull (Tokyo); 2012; 60(3):371-6. PubMed ID: 22382418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of heparin sulfate fractions on coagulation and hemostasis.
    Nader HB; Dietrich CP
    Proc Soc Exp Biol Med; 1974 Jun; 146(2):504-8. PubMed ID: 4275736
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.
    Cella G; Scattolo N; Luzzatto G; Stevanato F; Vio C; Girolami A
    J Med; 1986; 17(5-6):331-46. PubMed ID: 2953835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.